Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

441. A Synthesis of the Evidence: Interventions for Non-professional Caregivers of Individuals with Dementia

A Synthesis of the Evidence: Interventions for Non-professional Caregivers of Individuals with Dementia Management Briefs Enter search terms Button to search HSRD ® Inside VA Budget and Performance Inside the News Room National Observances Special Events » » » » » Management Briefs Health Services Research & Development Management Briefs Management eBriefs: Provide VA senior managers with results from VA Health Services Research in a concise and timely manner. , April 2019, Issue 152 , March

2010 Veterans Affairs - R&D

442. Video decision support affects patients? care choices in dementia care planning

Video decision support affects patients? care choices in dementia care planning Video decision support affects patients’ care choices in dementia care planning | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional (...) accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Video decision support affects patients’ care choices in dementia care planning Article Text Therapeutics Video decision support affects patients’ care choices in dementia care planning Statistics from Altmetric.com Question

2010 Evidence-Based Mental Health

443. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease Full Text available with Trip Pro

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease Due to the high prevalence of mild cognitive impairment (MCI) and dementia in Parkinson disease (PD), routine cognitive screening is important for the optimal management of patients with PD. The Montreal Cognitive Assessment (MoCA) is more sensitive than the commonly used Mini-Mental State Examination (MMSE) in detecting MCI and dementia in patients without PD, but its validity in PD has not been (...) established.A representative sample of 132 patients with PD at 2 movement disorders centers was administered the MoCA, MMSE, and a neuropsychological battery with operationalized criteria for deficits. MCI and PD dementia (PDD) criteria were applied by an investigator blinded to the MoCA and MMSE results. The discriminant validity of the MoCA and MMSE as screening and diagnostic instruments was ascertained.Approximately one third of the sample met diagnostic criteria for a cognitive disorder (12.9% PDD

2010 EvidenceUpdates

444. Determinants of survival in behavioral variant frontotemporal dementia Full Text available with Trip Pro

Determinants of survival in behavioral variant frontotemporal dementia Behavioral variant frontotemporal dementia (bvFTD) is a common cause of younger onset dementia. Little is known about its rate of progression but a recently identified subgroup seems to have an excellent prognosis. Other determinants of survival are unclear.We analyzed survival in a large group of clinically diagnosed bvFTD patients (n = 91) with particular attention to demographic and clinical features at presentation (...) diagnosis. The only factor associated with shorter survival was the presence of language impairment at diagnosis.Patients with definite frontotemporal dementia have a poor prognosis which is worse if language deficits are also present. This contrasts with the extremely good outcome in those with the phenocopy syndrome: of our 24 patients only 1 has died (of coincident pathology) despite, in some cases, many years of follow-up.

2010 EvidenceUpdates

445. Review of effects of physical activity on strength, balance, mobility and ADL performance in elderly subjects with dementia

Review of effects of physical activity on strength, balance, mobility and ADL performance in elderly subjects with dementia Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

446. Depression in older people is associated with increased risk of developing dementia

Depression in older people is associated with increased risk of developing dementia Depression in older people is associated with increased risk of developing dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Depression in older people is associated with increased risk of developing dementia Article Text Prognosis Depression in older people is associated with increased risk of developing dementia Statistics from

2010 Evidence-Based Mental Health

447. Spouses of people with incident dementia are at sixfold increased risk of developing dementia themselves

Spouses of people with incident dementia are at sixfold increased risk of developing dementia themselves Spouses of people with incident dementia are at sixfold increased risk of developing dementia themselves | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Spouses of people with incident dementia are at sixfold increased risk of developing dementia themselves Article Text Aetiology Spouses of people with incident dementia

2010 Evidence-Based Mental Health

448. A Systematic Evidence Review of the Signs and Symptoms of Dementia and Brief Cognitive Tests Available in VA

A Systematic Evidence Review of the Signs and Symptoms of Dementia and Brief Cognitive Tests Available in VA Evidence-based Synthesis Program A Systematic Evidence Review of the Signs and Symptoms of Dementia and Brief Cognitive Tests Available in VA Department of Veterans Affairs Health Services Research & Development Service April 2010 Investigators: Principal Investigator: Devan Kansagara, MD Research Associate: Michele Freeman, MPH Prepared for: Department of Veterans Affairs Veterans (...) Health Administration Health Services Research & Development Service Washington, DC 20420 Prepared by: VA Evidence-based Synthesis Program (ESP) Center Portland VA Medical Center Portland, OR Devan Kansagara, MD, Directorii A Systematic Evidence Review of the Signs and Symptoms of Dementia and Brief Cognitive Tests Available in VA Evidence-based Synthesis Program PREFACE HSR&D’s Evidence-based Synthesis Program (ESP) was established to provide timely and accurate syntheses of targeted healthcare

2010 Veterans Affairs Evidence-based Synthesis Program Reports

449. A Systematic Evidence Review of Interventions for Non-professional Caregivers of Individuals with Dementia

A Systematic Evidence Review of Interventions for Non-professional Caregivers of Individuals with Dementia Evidence-based Synthesis Program A Systematic Evidence Review of Interventions for Non-professional Caregivers of Individuals with Dementia Department of Veterans Affairs Health Services Research & Development Service October 2010 Prepared for: Department of Veterans Affairs Veterans Health Administration Health Services Research & Development Service Washington, DC 20420 Prepared (...) by: Evidence-based Synthesis Program (ESP) Center Portland VA Medical Center Portland, OR Devan Kansagara, MD, MCR, Director Investigators: Principal Investigator: Elizabeth Goy, PhD Co-Investigator: Devan Kansagara, MD, MCR Research Associate: Michele Freeman, MPHii Interventions for Non-professional Caregivers of Individuals with Dementia Evidence-based Synthesis Program PREFACE HSR&D’s Evidence-based Synthesis Program (ESP) was established to provide timely and accurate syntheses of targeted healthcare

2010 Veterans Affairs Evidence-based Synthesis Program Reports

450. Anticholinergic drugs increase the risk of cognitive decline and dementia in older people

Anticholinergic drugs increase the risk of cognitive decline and dementia in older people Anticholinergic drugs increase the risk of cognitive decline and dementia in older people | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Anticholinergic drugs increase the risk of cognitive decline and dementia in older people Article Text Therapeutics Anticholinergic drugs increase the risk of cognitive decline and dementia in older people Statistics

2010 Evidence-Based Mental Health

451. A systematic review of communication strategies for people with dementia in residential and nursing homes

A systematic review of communication strategies for people with dementia in residential and nursing homes Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

452. Supporting the dementia family caregiver: the effect of home care intervention on general well-being

Supporting the dementia family caregiver: the effect of home care intervention on general well-being Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2010 DARE.

453. [Pharmacological interactions between acetylcholinesterase inhibitors for treatment of dementia and further drugs occurring in patients of advanced age]

[Pharmacological interactions between acetylcholinesterase inhibitors for treatment of dementia and further drugs occurring in patients of advanced age] Interaktionen zwischen antidementiva und anderen medikamenten [Pharmacological interactions between acetylcholinesterase inhibitors for treatment of dementia and further drugs occurring in patients of advanced age] Interaktionen zwischen antidementiva und anderen medikamenten [Pharmacological interactions between acetylcholinesterase inhibitors (...) for treatment of dementia and further drugs occurring in patients of advanced age] Pertl D, Knaller C, Brunner-Ziegler S Record Status This is a bibliographic record of a published health technology assessment being undertaken by a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Pertl D, Knaller C, Brunner-Ziegler S. Interaktionen zwischen antidementiva und anderen medikamenten. [Pharmacological interactions between acetylcholinesterase

2010 Health Technology Assessment (HTA) Database.

454. The effectiveness of non-pharmacological interventions for behavioural and psychological symptom management for people with dementia in residential care settings.

The effectiveness of non-pharmacological interventions for behavioural and psychological symptom management for people with dementia in residential care settings. The effectiveness of non-pharmacological interventions for behavioural and psychological symptom management for people with dementia in residential care settings The effectiveness of non-pharmacological interventions for behavioural and psychological symptom management for people with dementia in residential care settings Basu (...) A, Brinson D Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Basu A, Brinson D. The effectiveness of non-pharmacological interventions for behavioural and psychological symptom management for people with dementia in residential care settings. Christchurch: Health Services Assessment Collaboration (HSAC). HSAC Report 3(19). 2010 Authors' conclusions

2010 Health Technology Assessment (HTA) Database.

455. A biobehavioral home-based intervention and the well-being of patients with dementia and their caregivers: the COPE randomized trial. Full Text available with Trip Pro

A biobehavioral home-based intervention and the well-being of patients with dementia and their caregivers: the COPE randomized trial. Optimal treatment to postpone functional decline in patients with dementia is not established.To test a nonpharmacologic intervention realigning environmental demands with patient capabilities.Prospective 2-group randomized trial (Care of Persons with Dementia in their Environments [COPE]) involving patients with dementia and family caregivers (community-living

2010 JAMA Controlled trial quality: predicted high

456. Efficacy and safety of galantamine hydrobromide in the treatment of mild to moderate dementia Full Text available with Trip Pro

Efficacy and safety of galantamine hydrobromide in the treatment of mild to moderate dementia Efficacy and safety of galantamine hydrobromide in the treatment of mild to moderate dementia Efficacy and safety of galantamine hydrobromide in the treatment of mild to moderate dementia Oremus M, Santaguida P, Raina P CRD summary The review concluded that galantamine was superior to placebo in patients with dementia after a maximum six-month follow-up. There was no evidence of a benefit compared (...) with donepezil. The authors stated that the evidence needed careful interpretation and further research was needed. Data limitations and potential review biases mean that the authors' recommendation to interpret the evidence carefully is appropriate. Authors' objectives To determine the efficacy and safety of galantamine hydrobromide in the treatment of mild to moderate dementia. Searching EMBASE, CINAHL, AgeLine, PsycINFO, MEDLINE, PREMEDLINE, AMED and Cochrane Central Register of Controlled Trials (CENTRAL

2010 DARE.

457. Angiotensin receptor blockers associated with decreased incidence and progression of dementia in older men with cardiovascular disease

Angiotensin receptor blockers associated with decreased incidence and progression of dementia in older men with cardiovascular disease Angiotensin receptor blockers associated with decreased incidence and progression of dementia in older men with cardiovascular disease | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies (...) , please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Angiotensin receptor blockers associated with decreased incidence and progression of dementia in older men

2010 Evidence-Based Mental Health

458. Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey. Full Text available with Trip Pro

Contribution of chronic diseases to disability in elderly people in countries with low and middle incomes: a 10/66 Dementia Research Group population-based survey. Disability in elderly people in countries with low and middle incomes is little studied; according to Global Burden of Disease estimates, visual impairment is the leading contributor to years lived with disability in this population. We aimed to assess the contribution of physical, mental, and cognitive chronic diseases to disability (...) , and the extent to which sociodemographic and health characteristics account for geographical variation in disability.We undertook cross-sectional surveys of residents aged older than 65 years (n=15 022) in 11 sites in seven countries with low and middle incomes (China, India, Cuba, Dominican Republic, Venezuela, Mexico, and Peru). Disability was assessed with the 12-item WHO disability assessment schedule 2.0. Dementia, depression, hypertension, and chronic obstructive pulmonary disease were ascertained

2009 Lancet

459. The clinical course of advanced dementia. Full Text available with Trip Pro

The clinical course of advanced dementia. Dementia is a leading cause of death in the United States but is underrecognized as a terminal illness. The clinical course of nursing home residents with advanced dementia has not been well described.We followed 323 nursing home residents with advanced dementia and their health care proxies for 18 months in 22 nursing homes. Data were collected to characterize the residents' survival, clinical complications, symptoms, and treatments and to determine (...) %) and pain (39.1%), were common. In the last 3 months of life, 40.7% of residents underwent at least one burdensome intervention (hospitalization, emergency room visit, parenteral therapy, or tube feeding). Residents whose proxies had an understanding of the poor prognosis and clinical complications expected in advanced dementia were much less likely to have burdensome interventions in the last 3 months of life than were residents whose proxies did not have this understanding (adjusted odds ratio, 0.12

2009 NEJM

460. Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia. (Abstract)

Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia. Rest-activity and sleep-wake cycles are controlled by the endogenous circadian rhythm generated by the suprachiasmatic nuclei (SCN) of the hypothalamus. Degenerative changes in the SCN appear to be a biological basis for circadian disturbances in people with dementia, and might be reversed by stimulation of the SCN by light.The review assesses the evidence of effectiveness of light (...) therapy in managing cognitive, sleep, functional, behavioural, or psychiatric disturbances associated with dementia.The Specialized Register of the Cochrane Dementia and Cognitive Improvement Group (CDCIG), The Cochrane Library, MEDLINE, EMBASE, PsycINFO, CINAHL and LILACS were searched on 4 March 2008 using the terms: "bright light*", "light box*", "light visor*", "dawn-dusk*", phototherapy, "photo therapy", "light therapy" "light treatment", light* . The CDCIG Specialized Register contains records

2009 Cochrane